AKN-028 is a novel tyrosine kinase (TKI) inhibitor and a potent inhibitor of FMS-like receptor tyrosine kinase 3 (FLT3) with oral activity for the study of acute myeloid leukemia (AML).
- Size: 1mg
- Purity: ≥97%
- Molecular Formula: C 1 7 H 1 4 N 6
- Molecular Weight: 302.33
- Brand: Saint Michael
- Catalogue No.: IAA11520-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review